Literature DB >> 9858585

Cyclin E2, a novel G1 cyclin that binds Cdk2 and is aberrantly expressed in human cancers.

J M Gudas1, M Payton, S Thukral, E Chen, M Bass, M O Robinson, S Coats.   

Abstract

A novel cyclin gene was discovered by searching an expressed sequence tag database with a cyclin box profile. The human cyclin E2 gene encodes a 404-amino-acid protein that is most closely related to cyclin E. Cyclin E2 associates with Cdk2 in a functional kinase complex that is inhibited by both p27(Kip1) and p21(Cip1). The catalytic activity associated with cyclin E2 complexes is cell cycle regulated and peaks at the G1/S transition. Overexpression of cyclin E2 in mammalian cells accelerates G1, demonstrating that cyclin E2 may be rate limiting for G1 progression. Unlike cyclin E1, which is expressed in most proliferating normal and tumor cells, cyclin E2 levels were low to undetectable in nontransformed cells and increased significantly in tumor-derived cells. The discovery of a novel second cyclin E family member suggests that multiple unique cyclin E-CDK complexes regulate cell cycle progression.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9858585      PMCID: PMC83919          DOI: 10.1128/MCB.19.1.612

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  43 in total

1.  Identification of a substrate-targeting domain in cyclin E necessary for phosphorylation of the retinoblastoma protein.

Authors:  B L Kelly; K G Wolfe; J M Roberts
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-03       Impact factor: 11.205

2.  Expression of NPAT, a novel substrate of cyclin E-CDK2, promotes S-phase entry.

Authors:  J Zhao; B Dynlacht; T Imai; T Hori; E Harlow
Journal:  Genes Dev       Date:  1998-02-15       Impact factor: 11.361

3.  Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes.

Authors:  A S Lundberg; R A Weinberg
Journal:  Mol Cell Biol       Date:  1998-02       Impact factor: 4.272

Review 4.  The dynamics of cyclin dependent kinase structure.

Authors:  D O Morgan
Journal:  Curr Opin Cell Biol       Date:  1996-12       Impact factor: 8.382

5.  Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients.

Authors:  P L Porter; K E Malone; P J Heagerty; G M Alexander; L A Gatti; E J Firpo; J R Daling; J M Roberts
Journal:  Nat Med       Date:  1997-02       Impact factor: 53.440

6.  Decreased levels of the cell-cycle inhibitor p27Kip1 protein: prognostic implications in primary breast cancer.

Authors:  C Catzavelos; N Bhattacharya; Y C Ung; J A Wilson; L Roncari; C Sandhu; P Shaw; H Yeger; I Morava-Protzner; L Kapusta; E Franssen; K I Pritchard; J M Slingerland
Journal:  Nat Med       Date:  1997-02       Impact factor: 53.440

7.  Cloning of cDNA sequences of hormone-regulated genes from the MCF-7 human breast cancer cell line.

Authors:  P Masiakowski; R Breathnach; J Bloch; F Gannon; A Krust; P Chambon
Journal:  Nucleic Acids Res       Date:  1982-12-20       Impact factor: 16.971

8.  The cyclin box and C-terminus of cyclins A and E specify CDK activation and substrate specificity.

Authors:  L E Horton; D J Templeton
Journal:  Oncogene       Date:  1997-01-30       Impact factor: 9.867

9.  Mutation of phosphoserine 389 affects p53 function in vivo.

Authors:  M Hao; A M Lowy; M Kapoor; A Deffie; G Liu; G Lozano
Journal:  J Biol Chem       Date:  1996-11-15       Impact factor: 5.157

10.  p21 is a critical CDK2 regulator essential for proliferation control in Rb-deficient cells.

Authors:  J Brugarolas; R T Bronson; T Jacks
Journal:  J Cell Biol       Date:  1998-04-20       Impact factor: 10.539

View more
  63 in total

1.  E2Fs regulate the expression of genes involved in differentiation, development, proliferation, and apoptosis.

Authors:  H Müller; A P Bracken; R Vernell; M C Moroni; F Christians; E Grassilli; E Prosperini; E Vigo; J D Oliner; K Helin
Journal:  Genes Dev       Date:  2001-02-01       Impact factor: 11.361

2.  Enhanced expression of cell cycle regulatory genes in virus-specific memory CD8+ T cells.

Authors:  Donald R Latner; Susan M Kaech; Rafi Ahmed
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

3.  Cyclin E constrains Cdk5 activity to regulate synaptic plasticity and memory formation.

Authors:  Junko Odajima; Zachary P Wills; Yasmine M Ndassa; Miho Terunuma; Karla Kretschmannova; Tarek Z Deeb; Yan Geng; Sylwia Gawrzak; Isabel M Quadros; Jennifer Newman; Manjusri Das; Marie E Jecrois; Qunyan Yu; Na Li; Frederic Bienvenu; Stephen J Moss; Michael E Greenberg; Jarrod A Marto; Piotr Sicinski
Journal:  Dev Cell       Date:  2011-09-22       Impact factor: 12.270

4.  New roles for cyclin E in megakaryocytic polyploidization.

Authors:  Alexia Eliades; Nikolaos Papadantonakis; Katya Ravid
Journal:  J Biol Chem       Date:  2010-04-14       Impact factor: 5.157

5.  miR-3687 Overexpression Promotes Bladder Cancer Cell Growth by Inhibiting the Negative Effect of FOXP1 on Cyclin E2 Transcription.

Authors:  Qipeng Xie; Caiyi Chen; Haiying Li; Jiheng Xu; Lei Wu; Yuan Yu; Shuwei Ren; Hongyan Li; Xiaohui Hua; Huiying Yan; Dapang Rao; Huxiang Zhang; Honglei Jin; Haishan Huang; Chuanshu Huang
Journal:  Mol Ther       Date:  2019-03-15       Impact factor: 11.454

6.  Cyclin E2 induces genomic instability by mechanisms distinct from cyclin E1.

Authors:  C Elizabeth Caldon; C Marcelo Sergio; Andrew Burgess; Andrew J Deans; Robert L Sutherland; Elizabeth A Musgrove
Journal:  Cell Cycle       Date:  2013-01-16       Impact factor: 4.534

7.  Differences in degradation lead to asynchronous expression of cyclin E1 and cyclin E2 in cancer cells.

Authors:  C Elizabeth Caldon; C Marcelo Sergio; Robert L Sutherland; Elizabeth A Musgrove
Journal:  Cell Cycle       Date:  2013-01-16       Impact factor: 4.534

8.  Cyclins E1 and E2 are required for endoreplication in placental trophoblast giant cells.

Authors:  Tiziana Parisi; Andreas R Beck; Nathalie Rougier; Tom McNeil; Linda Lucian; Zena Werb; Bruno Amati
Journal:  EMBO J       Date:  2003-09-15       Impact factor: 11.598

9.  Global transcriptomic analysis of model human cell lines exposed to surface-modified gold nanoparticles: the effect of surface chemistry.

Authors:  E M Grzincic; J A Yang; J Drnevich; P Falagan-Lotsch; C J Murphy
Journal:  Nanoscale       Date:  2015-01-28       Impact factor: 7.790

10.  Aberrant cell cycle progression and endoreplication in regenerating livers of mice that lack a single E-type cyclin.

Authors:  Yulia A Nevzorova; Darjus Tschaharganeh; Nikolaus Gassler; Yan Geng; Ralf Weiskirchen; Piotr Sicinski; Christian Trautwein; Christian Liedtke
Journal:  Gastroenterology       Date:  2009-05-13       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.